AbbVie Extends Reach Across Dermatology Markets With Dual Regulatory Wins

기사 요약

FDA approves AbbVie Skyrizi for pediatric psoriasis, while EU’s CHMP backs Rinvoq for vitiligo and alopecia. Read the latest updates.